|
|
||||||||
Ann Thorac Surg 2000;70:1446
© 2000 The Society of Thoracic Surgeons
a Chung Shan Medical and Dental College Hospital, No. 110, Taiwan,
e-mail: tsai{at}flower.csh.org.tw
To the Editor
We read with interest the articles by Takahashi and colleagues [1] and Tashiro and associates [2] regarding the extension of internal mammary arteries with interposing radial artery grafts to allow for multiple arterial revascularization. In addition to multiple revascularization, we found that lengthening of the internal mammary graft conduit is also useful in minimally invasive direct coronary artery bypass (MIDCAB). The limited exposure of MIDCAB occasionally impedes adequate harvesting of the internal mammary artery (IMA). To prevent undue tension on the mammary graft, we routinely skeletonize the IMA and add an interposition graft to the distal end of the IMA. Because of a combination of socioeconomic reasons and patients aesthetic preference for avoiding upper extremity incisions, we routinely use saphenous veins instead of radial arteries as interposition grafts.
From May 1996 to December 1999 we performed left IMAleft anterior descending artery MIDCAB in 33 patients (30 men, mean age 65.3 years). Ten patients (8 men, mean age 62 years) required lengthening with autologous saphenous vein graft (SVG) segments. The average length of SVG required was 4.6 cm. There was one operative mortality in the MIDCAB without SVG group due to postoperative left ventricular aneurysm rupture. There was no operative mortality in the MIDCAB with SVG group. Patients who received MIDCAB without SVG had uneventful recovery. There were two reported complications in the MIDCAB with SVG group: one subcutaneous emphysema and one transient atrial fibrillation. Follow-up study of both groups of patients revealed no graft failure or IMA malperfusion in either group (mean follow-up, 29 months).
Lengthening of IMA with SVG can be safely performed in MIDCAB when IMA harvesting is limited by exposure and when the use of radial artery interposition grafts is contraindicated. Intermediate-term follow-ups show comparable patency results with conventional MIDCAB.
References
Related Articles
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |